About us
Pricing
Contact
Subscribe
Journals
Articles
Research Areas
Publishers
Trends
World Map
Compare
Site Map
A
Andrea L. Webber
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID https://orcid.org/0000-0003-2463-0878
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—
Top Publications
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
The Lancet Oncology
2018
2,498 citations
Andrea L. Webber · Scinovex
